Patent Expiration and the Global Generics Window: A Strategic Guide for American Patients Ready to Save
When a blockbuster drug loses its patent protection, generic manufacturers around the world move swiftly—often faster than the US market responds. Understanding this global generics window could help American patients dramatically reduce their medication costs during critical transition periods.